Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)

Condition:   Atopic Dermatitis Interventions:   Drug: Tralokinumab;   Drug: Placebo;   Biological: Tdap vaccine;   Biological: Meningococcal vaccine Sponsor:   LEO Pharma Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials